Today, the FDA announced the availability of a draft guidance on biosimilar interchangeability, entitled “Considerations in Demonstrating Interchangeability With a Reference Product,” which is currently available on FDA’s website. The official announcement is scheduled to be published in the Federal Register tomorrow, January 18, 2017. This guidance provides an overview…